Correlation of apparent diffusion coefficient measured by diffusion-weighted MRI and clinicopathologic features in pancreatic cancer patients

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 20, Issue 2, 2013, Pages 243-248

  Hayano, Koichi ^a,b   Miura, Fumihiko ^a   Amano, Hodaka ^a   Toyota, Naoyuki ^a   Wada, Keita ^a   Kato, Kenichiro ^a   Sano, Keiji ^a   Takeshita, Koji ^a   Aoyagi, Tomoyoshi ^b   Shuto, Kiyohiko ^b   Matsubara, Hisahiro ^b   Asano, Takehide ^a   Takada, Tadahiro ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Apparent diffusion coefficient; Diffusion weighted imaging; Magnetic resonance imaging; Pancreatic cancer

Indexed keywords

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; NERVE PLEXUS; PANCREAS CANCER; PANCREAS RESECTION; PHYSICAL PARAMETERS; PORTAL VEIN; PREOPERATIVE EVALUATION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; TUMOR INVASION; TUMOR VOLUME;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PREOPERATIVE PERIOD; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84879692358     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-011-0491-5     Document Type: Article

References (31)

1. Freeny PC, Marks WM, Ryan JA, Traverso LW. Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT. Radiology. 1988;166:125-33.
2. O'Malley ME, Boland GW, Wood BJ, Fermanz-del Castillo C, Warshaw AL, Mueller PR. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR Am J Roentgenol. 1999;173:1513-8.
3. Gabata T, Matsui O, Kadoya M, Yoshikawa J, Miyayama S, Takashima T, et al. Small pancreatic adenocarcinoma: efficacy of MR imaging with fat suppression and gadolinium enhancement. Radiology. 1994;193:683-8.
4. Johnson PT, Outwater EK. Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging. Radiology. 1999;212:213-8.
5. LeBihan D, Turner R. Intravoxel incoherent motion imaging using spin echos. Magn Reson Med. 1991;19:221-7.
6. Lebihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravixel incoherent motions: application to diffusion and perfusion neurogenic disorders. Radiology. 1986;161:401-7.
7. Koh DM, Padhani AR. Diffusion-weighted MRI: a new functional clinical technique for tumor imaging. Br J Radiol. 2006;79:633-5.
8. LeBihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol. 1992;159:591-9.
9. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging. 1999;24:456-61.
10. Mürtz P, Flacke S, Träber F, van den Brink JS, Gieseke J, Schild HH. Abdomen: diffusion-weighted MR imaging with pulse-triggered single-shot sequences. Radiology. 2002;224:258-64.
11. Yoshikawa T, Kawamitsu H, Mitchell DG, Ohno Y, Ku Y, Seo Y, et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol. 2006;187:1521-30.
12. Herneth AM, Guccione S, Bednarski M. Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. Eur J Radiol. 2003;45:208-13.
13. Roth Y, Tichler T, Kostenich G, Ruiz-Cabello J, Maiser SE, Cohen JS, et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology. 2004;232:685-92.
14. Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 2002;360:307-8.
15. Muraoka N, Uematsu H, Kimura H, Imamura Y, Fujiwara Y, Murakami M, et al. Apparent diffusion coefficient in pancreatic cancer: characterization and histopathological correlations. J Magn Reson Imaging. 2008;27:1302-8.
16. Niwa T, Ueno M, Ohkawa S, Yoshida T, Doiuchi T, Ito K, et al. Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy. Br J Radiol. 2009;82:28-34.
17. International Union Against Cancer (UICC). TNM classification of malignant tumors. 6th ed. New York: Weily-Liss; 2002.
18. Miura F, Takada T, Amano H, Yoshida M, Furui S, Takeshita K. Diagnosis of pancreatic cancer. HPB (Oxford). 2006;8:337-42.
19. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188:1622-35.
20. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354:379-86.
21. Peak AS, Sheller A. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis. Ann Pharmacother. 2007;41:1481-5.
22. Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 1991;161:120-5.
23. Takai S, Satoi S, Toyokawa H, Yanagimoto H, Sugimoto N, Tsuji K, et al. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas. 2003;26:243-9.
24. Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, et al. Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. J Am Coll Surg. 2010;211:196-204.
25. Nakao A, Harada A, Nonami T, Kaneko T, Takagi H. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas. 1996;12:357-61.
26. Cai YQ, Guo Y, Cai ZL, Gao YG, An NY, Ma L, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging. 2002;16:172-8.
27. Hatakenaka M, Soeda H, Yabuuchi H, Matsuo Y, Kamitani T, Oda Y, et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci. 2008;7:23-9.
28. Korc M. Pancreatic cancer-associated stroma production. Am J Surg. 2007;194:S84-6.
29. Akisik MF, Aisen AM, Sandrasegaran K, Jennings SG, Lin C, Sherman S, et al. Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement. Radiology. 2009;250:103-9.
30. Taouli B, Tolia AJ, Losada M, Babb JS, Chan ES, Bannan MA, et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol. 2007;189:799-806.
31. Fattahi R, Balci NC, Perman WH, Hsueh EC, Alkaade S, Havlioqlu N, et al. Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging. 2009;29:350-6.